A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

Kerynn Morss is still looking for a donor match for her son Broeden Sabin, who was diagnosed with acute myeloid leukemia in ...

New research into acute myeloid leukemia could change future treatment approaches.

Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...

While not every patient with AML develops skin involvement, it can be one of the earliest visible signs that something systemic is occurring.

The review highlights current strategies for myeloid cell targeting and novel agents targeting myeloid cells for cancer treatment. Myeloid cells are innate immune cells, and they include macrophages, ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than those ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

Leukemia is a type of cancer that impacts cells in the bone marrow. There are several types of leukemia. Acute myeloid leukemia (AML) is one of them. While AML mostly affects older adults, younger ...

Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment Data on 221 newly diagnosed patients with AML ...